Stockreport

pSivida's Durasert shows treatment benefit at month 12 in second late-stage PSU study, U.S. marketing application submitted [Seeking Alpha]

PSIVIDA  (PSDV) 
Last psivida earnings: 2/7 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.psivida.com
PDF pSivida's Durasert shows treatment benefit at month 12 in second late-stage PSU study, U.S. marketing application submittedResults from a second Phase 3 clinical trial e [Read more]